BioLine RX Ltd ADR buy stratec
Start price
08.12.17
/
50%
€223.25
Target price
03.12.18
€608.85
Performance (%)
-36.36%
End price
03.12.18
€142.07
Summary
This prediction ended on 03.12.18 with a price of €142.07. Massive losses of -36.36% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioLine RX Ltd ADR | - | - | - | - |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% | 63.911% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% | 108.934% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% | 57.329% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% | 67.940% |
Comments by stratec for this prediction
In the thread BioLine RX Ltd ADR diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 08.12.2017 der Buy-Einschätzung von tamam mit dem Kursziel 3$ zu.Überschrift: BioLineRx in partnership with Novartis and collaboration with Roche
(Vom Mitglied beendet)
Stopped prediction by stratec for BioLine RX Ltd ADR
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€142.07
02.12.18
02.12.18
€45.00
12.05.20
12.05.20
-98.91%
12.05.20
12.05.20
